Onkos Surgical
-
Biologics
MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants
WASHINGTON, June 20, 2024 /PRNewswire/ — MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory…
Read More » -
Regulatory
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
– Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to…
Read More » -
Top Stories
Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center
Onkos Surgical manufacturing facility in Parsippany, NJ Company expands capabilities of its Precision Orthopaedics platform PARSIPPANY, N.J., July 20, 2023 /PRNewswire/ — Onkos…
Read More » -
Recon
Onkos Surgical Receives FDA 510(k) Clearance for 3D Printed, Patient-Specific Pelvic Reconstruction System
Company expands its portfolio of musculoskeletal oncology and complex orthopaedic solutions to include conditions of the pelvis PARSIPPANY, N.J., July 14,…
Read More » -
Financial
Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis
Company expands musculoskeletal oncology portfolio with device to treat pediatric bone cancer PARSIPPANY, N.J., June 14, 2022 /OrthoSpineNews/ — Onkos Surgical, Inc., a rapidly…
Read More » -
Extremities
Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surgery
The new offering, available as part of the ELEOS™ Limb Salvage System, is designed to help support bone ingrowth in…
Read More » -
Hospitals
3D Systems’ VSP Orthopaedics Receives FDA 510(k) Clearance — Opening the Door to Personalized Treatment of Complex Musculoskeletal Disease
ROCK HILL, S.C., Sept. 26, 2019 /PRNewswire/ — 3D Systems (NYSE: DDD) announced that the Food and Drug Administration (FDA) has provided 510(k) clearance to…
Read More » -
Biologics
Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology
COLLEYVILLE, Texas, Aug. 28, 2019 /PRNewswire/ — Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first…
Read More » -
Extremities
Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions
PARSIPPANY, N.J., March 6, 2018 /PRNewswire/ — Onkos Surgical, Inc. announced today that it signed a 4-year agreement with 3D Systems (NYSE: DDD) to…
Read More » -
Financial
Stealth startup Onkos gets Series A, partnership for next-gen bone cancer surgery
By Stacy Lawrence Onkos Surgical’s stated mission is to transform surgical oncology, but it hasn’t divulged the details yet on…
Read More »